Publications by authors named "David Mollerup"

Claim this Profile
S
Safety and clinical effect of subcutaneous human interleukin-21 in patients with metastatic melanoma or renal cell carcinoma: a phase I trial.
Henrik Schmidt, Janet Brown, Ulrik Mouritzen, Peter Selby, Kirsten Fode, David Hal Mollerup

Clin Cancer Res· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory approvals in a large multinational clinical trial: the ESPRIT experience.
Laura A McNay, Jorge A Tavel, Karen Oseekey, Cathy M McDermott, David Mollerup

Control Clin Trials· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis